4.7 Review

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action

期刊

出版社

MDPI
DOI: 10.3390/ijms21228870

关键词

CBD; network pharmacology; pain; neuropathic; osteoarthritis

资金

  1. National Science Centre, Poland [OPUS12 UMO-2016/23/B/NZ7/01143]
  2. Departmental Statutory funds (Maj Institute of Pharmacology, Polish Academy of Sciences)

向作者/读者索取更多资源

Cannabis has a long history of medical use. Although there are many cannabinoids present in cannabis, Delta 9tetrahydrocannabinol (Delta 9-THC) and cannabidiol (CBD) are the two components found in the highest concentrations. CBD itself does not produce typical behavioral cannabimimetic effects and was thought not to be responsible for psychotropic effects of cannabis. Numerous anecdotal findings testify to the therapeutic effects of CBD, which in some cases were further supported by research findings. However, data regarding CBD's mechanism of action and therapeutic potential are abundant and omnifarious. Therefore, we review the basic research regarding molecular mechanism of CBD's action with particular focus on its analgesic potential. Moreover, this article describes the detailed analgesic and anti-inflammatory effects of CBD in various models, including neuropathic pain, inflammatory pain, osteoarthritis and others. The dose and route of the administration-dependent effect of CBD, on the reduction in pain, hyperalgesia or allodynia, as well as the production of pro and anti-inflammatory cytokines, were described depending on the disease model. The clinical applications of CBD-containing drugs are also mentioned. The data presented herein unravel what is known about CBD's pharmacodynamics and analgesic effects to provide the reader with current state-of-art knowledge regarding CBD's action and future perspectives for research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据